History
  • No items yet
midpage
Patricia Lewis v. Pfizer, Inc.
2:14-cv-01848
| C.D. Cal. | May 23, 2017
Read the full case

Background

  • Hundreds of California state-court suits (over 140 actions, ~4,800 plaintiffs total) alleged Lipitor caused Type II diabetes; many were coordinated via a Judicial Council Coordinated Proceeding (JCCP) titled “Lipitor Cases.”
  • Plaintiffs filed an amended coordination petition seeking coordination “for all purposes” and represented they would seek to add additional cases via add-on petitions; the JCCP initially included only three cases and later a total of nine after add-ons; 53 add-on petitions remain pending.
  • At a February 2014 status conference JCCP counsel presented a list of many additional Lipitor cases and expressed intent to add them to the JCCP, but the state-court add-on procedure required affirmative add-on filings (and allowed opposition) before cases would be added.
  • Pfizer removed the cases to federal court under CAFA’s mass-action provision (28 U.S.C. § 1332(d)(11)) claiming the monetary claims of 100+ plaintiffs were proposed to be tried jointly; cases were transferred to MDL, which rejected diversity grounds and recommended remand; matters returned to this district.
  • Plaintiffs moved to remand, arguing fewer than 100 plaintiffs had voluntarily and affirmatively proposed a joint trial; the district court granted remand because only 65 plaintiffs had made such proposals via the amended petition or add-on petitions.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether a coordination petition that requests coordination "for all purposes" constitutes a proposal to try cases jointly under CAFA The amended petition sought only coordination for pretrial discovery; plaintiffs did not propose a joint trial for 100+ plaintiffs The amended petition and JCCP counsel’s statements constituted a proposal to try claims jointly (including intentions to add many more plaintiffs), satisfying CAFA’s proposal requirement The petition did propose joint trials (Corber controls on "for all purposes" language), but that proposal was made only on behalf of the plaintiffs named in the petition/add-ons, not all Lipitor plaintiffs
Whether 100 or more plaintiffs proposed joint trial (who must make the proposal) Only plaintiffs who filed express add-on petitions or were named in the amended petition voluntarily proposed joint trial; that number is 65, below CAFA’s 100 threshold JCCP counsel’s public statements, coordination procedures, case cover sheets, and the judge’s assignment implied that 100+ plaintiffs were proposed to be tried jointly Held that only the 65 plaintiffs who affirmatively sought coordination proposed joint trial; CAFA’s 100-plaintiff threshold not met, so no mass-action jurisdiction
Whether counsel’s statements or administrative filings (civil cover sheets, notices of related cases) suffice as affirmative proposals Such administrative or predictive statements are insufficient; the clients themselves must voluntarily propose joint trial JCCP counsel’s communications and filings reasonably indicated intent to bind additional plaintiffs and thus satisfy the "proposal" requirement Court held administrative filings and counsel’s general statements do not substitute for each plaintiff’s voluntary and affirmative proposal
Whether the state judge’s coordination order itself constituted a proposal to try 100+ plaintiffs jointly The judge’s order required add-on procedures and did not automatically bind plaintiffs; thus it did not constitute a 100+ plaintiff proposal Defendant argued the judge’s assignment and order effectively proposed joint trial for all related Lipitor cases Court held the judge’s order did not itself propose a joint trial of 100+ plaintiffs because add-on procedures required affirmative inclusion of each case

Key Cases Cited

  • Corber v. Xanodyne Pharm., Inc., 771 F.3d 1218 (9th Cir. 2014) (petition seeking coordination "for all purposes" can constitute a voluntary proposal to try cases jointly under CAFA)
  • Briggs v. Merck Sharp & Dohme, 796 F.3d 1038 (9th Cir. 2015) (a proposal for CAFA mass-action jurisdiction must be a voluntary, affirmative act; defendants’ actions alone are insufficient)
  • Tanoh v. Dow Chem. Co., 561 F.3d 945 (9th Cir. 2009) (distinguishing mass actions from class actions and addressing coordination/removal issues)
  • Scimone v. Carnival Corp., 720 F.3d 876 (11th Cir. 2013) (proposal must be more than a mere prediction; it must be an affirmative act)
  • Parson v. Johnson & Johnson, 749 F.3d 879 (10th Cir. 2014) (treating a proposal as a voluntary, intentional act for CAFA purposes)
Read the full case

Case Details

Case Name: Patricia Lewis v. Pfizer, Inc.
Court Name: District Court, C.D. California
Date Published: May 23, 2017
Docket Number: 2:14-cv-01848
Court Abbreviation: C.D. Cal.